Anti CD19/BCMA CAR Gene Therapy for Autoimmune Diseases

NCT07121777 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

18

Enrollment

OTHER_GOV

Sponsor class

Conditions

Autoimmune Diseases

Interventions

DRUG: Anti-CD19/BCMA CAR gene vector injection will be injected intravenously on a one-time basis

Sponsor

Anhui Provincial Hospital